Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2018

01-08-2018 | Review

Clinical Guidelines Update on the Diagnosis and Management of Barrett’s Esophagus

Authors: Michelle Clermont, Gary W. Falk

Published in: Digestive Diseases and Sciences | Issue 8/2018

Login to get access

Abstract

Barrett’s esophagus is a condition in which metaplastic columnar epithelium replaces stratified squamous epithelium in the distal esophagus. This condition occurs due to chronic gastroesophageal reflux disease and is a risk factor for the development of esophageal adenocarcinoma. Multiple clinical guidelines have been published around the world in recent years to assist gastroenterologists in the management of these patients and have evolved as new data have become available. While some information such as surveillance technique has not drastically changed, there has been an evolution over the years in diagnostic criteria, screening and endoscopic therapy with a variety of subtle differences among the different guidelines. Herein, we highlight areas of agreement and disagreement on definitions, screening, surveillance, and treatment techniques among these guidelines for the optimal management of Barrett’s esophagus patients.
Literature
1.
go back to reference Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017;49:191–198.CrossRefPubMed Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017;49:191–198.CrossRefPubMed
2.
go back to reference Shaheen NJ, Falk GW, Iyer PG, Gerson LB. American College of gastroenterology. ACG clinical guideline: diagnosis and management of Barrett’s Esophagus. Am J Gastroenterol. 2016;111:30–50.CrossRefPubMed Shaheen NJ, Falk GW, Iyer PG, Gerson LB. American College of gastroenterology. ACG clinical guideline: diagnosis and management of Barrett’s Esophagus. Am J Gastroenterol. 2016;111:30–50.CrossRefPubMed
3.
go back to reference Whiteman DC, Appleyard M, Bahin FF, et al. Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol. 2015;30:804–820.CrossRefPubMed Whiteman DC, Appleyard M, Bahin FF, et al. Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol. 2015;30:804–820.CrossRefPubMed
4.
go back to reference Fock KM, Talley N, Goh KL, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus. Gut. 2016;65:1402–1415.CrossRefPubMed Fock KM, Talley N, Goh KL, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus. Gut. 2016;65:1402–1415.CrossRefPubMed
5.
go back to reference Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.CrossRefPubMed Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.CrossRefPubMed
6.
go back to reference ASGE Standards of Practice Committee, Evans JA, Early DS, et al. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76:1087–1094.CrossRef ASGE Standards of Practice Committee, Evans JA, Early DS, et al. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76:1087–1094.CrossRef
7.
go back to reference American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–1091.CrossRef American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–1091.CrossRef
8.
go back to reference Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–1399.CrossRefPubMed Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–1399.CrossRefPubMed
9.
go back to reference Ganz RA, Allen JI, Leon S, Batts KP. Barrett’s esophagus is frequently over diagnosed in clinical practice: results of the Barrett’s Esophagus Endoscopic Revision (BEER) study. Gastrointest Endosc. 2014;79:565–573.CrossRefPubMed Ganz RA, Allen JI, Leon S, Batts KP. Barrett’s esophagus is frequently over diagnosed in clinical practice: results of the Barrett’s Esophagus Endoscopic Revision (BEER) study. Gastrointest Endosc. 2014;79:565–573.CrossRefPubMed
10.
go back to reference Thota PN, Vennalaganti P, Vennelaganti S, et al. Low risk of high-grade dysplasia or esophageal adenocarcinoma among patients with Barrett’s esophagus less than 1 cm (irregular Z Line) within 5 years of index endoscopy. Gastroenterology. 2017;152:987–992.CrossRefPubMed Thota PN, Vennalaganti P, Vennelaganti S, et al. Low risk of high-grade dysplasia or esophageal adenocarcinoma among patients with Barrett’s esophagus less than 1 cm (irregular Z Line) within 5 years of index endoscopy. Gastroenterology. 2017;152:987–992.CrossRefPubMed
11.
go back to reference Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett’s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007;102:1154–1161.CrossRefPubMed Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett’s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007;102:1154–1161.CrossRefPubMed
12.
go back to reference Bhat SK, McManus DT, Coleman HG, et al. Oesophageal adenocarcinoma and prior diagnosis of Barrett’s oesophagus: a population-based study. Gut. 2015;64:20–25.CrossRefPubMed Bhat SK, McManus DT, Coleman HG, et al. Oesophageal adenocarcinoma and prior diagnosis of Barrett’s oesophagus: a population-based study. Gut. 2015;64:20–25.CrossRefPubMed
13.
go back to reference Fock KM, Talley N, Goh KL, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus. Gut. 2016;65:1402–1415.CrossRefPubMed Fock KM, Talley N, Goh KL, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus. Gut. 2016;65:1402–1415.CrossRefPubMed
14.
go back to reference di Pietro M, Fitzgerald RC. BSG Barrett’s guidelines working group. Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett’s oesophagus with low-grade dysplasia. Gut. 2018;67:392–393.CrossRefPubMed di Pietro M, Fitzgerald RC. BSG Barrett’s guidelines working group. Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett’s oesophagus with low-grade dysplasia. Gut. 2018;67:392–393.CrossRefPubMed
15.
go back to reference Katzka DA, Falk GW. Management of low-grade dysplasia in Barrett’s Esophagus: incremental progress continues. Gastroenterology. 2017;152:928–932.CrossRefPubMed Katzka DA, Falk GW. Management of low-grade dysplasia in Barrett’s Esophagus: incremental progress continues. Gastroenterology. 2017;152:928–932.CrossRefPubMed
Metadata
Title
Clinical Guidelines Update on the Diagnosis and Management of Barrett’s Esophagus
Authors
Michelle Clermont
Gary W. Falk
Publication date
01-08-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5070-z

Other articles of this Issue 8/2018

Digestive Diseases and Sciences 8/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.